Please subscribe to our new YouTube channel!! ✨ https://lnkd.in/gve4C_rj
Radiomedix, Inc.
Biotechnology Research
Houston, Texas 3,531 followers
Innovating Theranostics
About us
RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory system for synthesis of PET tracers for the research and clinical markets. RadioMedix has also established two service facilities for academic and industrial partners: cGMP Manufacturing Suite for clinical probe development and Molecular Imaging Facility for evaluation of agents in animal models.
- Website
-
http://www.radiomedix.com
External link for Radiomedix, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Houston, Texas
- Type
- Privately Held
- Founded
- 2006
- Specialties
- Innovative targeted radiopharmaceuticals, Biotechnology, Generator-produced radiopharmaceuticals based on Gallium-68, and Development of a new diagnostic and therapeutic radiolabeled agents
Locations
-
Primary
Get directions
9701 Richmond Avenue, Suite 222,
Houston, Texas 77042, US
-
Get directions
19705 Aldine Westfield Rd
Humble, Texas 77338, US
Employees at Radiomedix, Inc.
Updates
-
🎇Happy Fourth of July! our office will be closed on July 4th as we celebrate the 4th of July, we honor the birth of the United States of America—the day when the Declaration of Independence was adopted in 1776 Let us remember the sacrifices of those who fought for our liberty and reflect on the principles that unite us. Our offices will be closed today, but we’ll be back to serve you tomorrow, July 5th. Enjoy the fireworks, spend time with loved ones, and embrace the spirit of unity that defines our nation. #radiomedix #4thjuly #radiopharmaceuticals #Oranomed #radiotherapy #nucmed #nuclearmedicine🧪
-
-
RadioMedix will be attending this year’s SNMMI❗️ Join us at Booth #1617 to learn more about our vision of treating Cancer with alpha therapeutics and our state-of-the art manufacturing facility in Houston Texas❗️ #SNMMI #radiomedix #toronto #snmmi24 #radiopharmaceutical #radiotherapy #nucmed #nuclearmedicine🧪
-
📢 Exciting Milestone Achieved in Alphamedix Phase 2 Study! With our partner Radiomedix, Inc. , we're proud to announce that the last patient in the PRRT-naive cohort of our Alphamedix™ Phase 2 study has received the final dose of study therapy ! We look forward to reporting data on the study in 2024, which we believe will show that AlphaMedix™ will provide substantial benefit over currently approved therapies for patients with metastatic or inoperable SSTR-expressing neuroendocrine tumors. This marks a significant step forward in advancing the development of targeted alphatherapies with lead-212 ! 🚀 #OranoMed #RLT #Radiopharmaceuticals
-
-
We are excited to share that the Inc Magazine's upcoming issue will feature the life story of Dr. Ebrahim (Abe) S. Delpassand, the CEO of Radio Medix. In the interview, he will discuss his groundbreaking work in radiopharmaceuticals and the future of cancer care. We are excited to offer readers a glimpse into Dr. Delpassand’ s visionary approach. #RadioMedix #DrEbrahimDelpassand #PET #Cancer #NETcancerday #Nuclearmedicine #PSMA #PsmaPET https://lnkd.in/gDr2YFrJ